Webb13 apr. 2024 · Phio Pharmaceuticals Corporation Aktie ISIN: US71880W4024 · WKN: A3D451 · SYM: PHIO 5,710 USD -1,21 % -0,070 USD Letzter Kurs 06.04.23 · NYSE 5,440 USD 100 STK Geldkurs 06.04.23 6,000 USD 100... Webb22 feb. 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAi technology is designed to make immune cells more effective in killing tumor cells. Corporate Presentation The following is an investor update, effective January 2024, presented by Robert Bitterman. Mr.
PHIO Phio Pharmaceuticals Corp - Stocktwits
WebbPhio Pharmaceuticals Corp. is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL™) … WebbPHIO - Phio Pharmaceuticals Corp. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save … canadian tax benefits 2022
Phio Pharmaceuticals About Us
Webb2024-11-14 - BlackRock Inc. has filed a 13F-HR form disclosing ownership of 19 shares of Phio Pharmaceuticals Corp (US:PHIO) with total holdings valued at $0 USD as of 2024 … Webb30 mars 2024 · Phio Pharmaceuticals - PHIO News Today $5.99 +0.16 (+2.74%) (As of 03/30/2024 10:41 AM ET) Compare Today's Range $5.75 $5.99 50-Day Range $0.51 $6.85 52-Week Range $3.90 $29.04 Volume 1,039 shs Average Volume 36,447 shs Market Capitalization $6.89 million P/E Ratio N/A Dividend Yield N/A Price Target N/A Profile … WebbThe average one-year price target for Phio Pharmaceuticals is $73.44 The forecasts range from a low of $72.72 to a high of $75.60. Update Frequency: Monthly PHIO / Phio … fisherman christmas gifts